Discovery of a Thermostable Nigerose Phosphorylase for the Efficient Chemoenzymatic Radiosynthesis of a <i>S. aureus</i>-Targeted <sup>18</sup>F-Disaccharide.
Where this comes from
- Record sourced from PubMed, PMID 42350031.
- Also identified by DOI 10.2967/jnumed.125.271829 and PMC identifier 13435556.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
<i>Staphylococcus aureus</i> is a leading cause of life-threatening infections worldwide. The diagnosis and treatment of <i>S. aureus</i> infections are further complicated by the global rise of antimicrobial resistance. Therefore, rapid detection of active <i>S. aureus</i> remains a critical unmet need to provide effective infection management. In this study, we identified 2-deoxy-2-[<sup>18</sup>F]-fluorosakebiose ([<sup>18</sup>F]FSK) as an optimal radiotracer to detect active <i>S. aureus</i> and established its efficient chemoenzymatic radiosynthesis to facilitate clinical translation. <b>Methods</b>: Several [<sup>18</sup>F]FDG-derived disaccharides were obtained via reverse phosphorolysis: [<sup>18</sup>F]FSK (α-1,3-linked), 2-deoxy-[<sup>18</sup>F]-fluoromaltose (α-1,4-linked), 2-deoxy-2-[<sup>18</sup>F]-fluorolaminaribiose (β-1,3-linked), and 2-deoxy-2-[<sup>18</sup>F]-fluorocellobiose (β-1,4-linked). These tracers were screened in vitro in multiple <i>S. aureus</i> isolates to identify bacterial incorporation. The lead candidate, [<sup>18</sup>F]FSK, was further characterized via biodistribution and dosimetry analyses and evaluated in a <i>S. aureus</i> myositis model to assess antimicrobial treatment response. Finally, to promote the clinical translation of [<sup>18</sup>F]FSK, 2 different radiosynthetic strategies were investigated: reverse phosphorolysis of [<sup>18</sup>F]FDG using maltose phosphorylase and using newly identified nigerose (also called sakebiose) phosphorylases. <b>Results</b>: Nigerose phosphorylase-derived [<sup>18</sup>F]FSK was selected as the optimal radiotracer for detecting <i>S. aureus</i> because of its consistent and robust uptake in multiple <i>S. aureus</i> isolates. [<sup>18</sup>F]FSK demonstrated favorable distribution and elimination over time, with minimal nonspecific signals in uninfected organs. The estimated human effective doses indicated an effective dose comparable to that of [<sup>18</sup>F]FDG. The radiosynthesis of [<sup>18</sup>F]FSK, initially obtained as an accidental byproduct of maltose phosphorylase catalysis, was further improved using a nigerose phosphorylase originating from thermostable <i>Spirochaeta thermophila</i>, enabling nearly quantitative conversion of [<sup>18</sup>F]FDG to [<sup>18</sup>F]FSK (up to 97%). <b>Conclusion</b>: We demonstrated that [<sup>18</sup>F]FSK is a potent and robust PET radiotracer for the detection of active <i>S. aureus</i> in vivo and aids in the selection of an appropriate antimicrobial treatment. These findings highlight the potential use of [<sup>18</sup>F]FSK in promoting the effective management of <i>S. aureus</i> infections in clinical settings.
Medical subject headings
- Staphylococcus aureus
- Disaccharides
- Glucosyltransferases
- Fluorine Radioisotopes
- Temperature